Economy · Full coverage
Credit Card Firm Calcal Deal Collapses Over Super-Pharm Holdings
How 5 Israeli newsrooms covered this story — translated into English and compared side by side.
100% center
Center 2Unrated 3
By מערכת ice
First reported by Calcalist · 2 hours ago
What happened
A 4 billion shekel deal for the sale of Israeli credit card company Calcal has fallen apart because the buyer refused to divest its stake in Super-Pharm, a condition set by the Antitrust Authority. Discount Bank, the seller, is now preparing to take Calcal public instead.
- 01Calcal sale collapses due to Antitrust Authority's demand on Super-Pharm.
- 02Buyer Union Group refused to sell its Super-Pharm stake.
- 03Antitrust Authority feared data access and competitive advantage.
- 04Deal was valued at approximately 4 billion shekels.
- 05Discount Bank now plans an IPO for Calcal by May 2027.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 5 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
MakoCenter · Hebrew2 hours ago
Israel's Competition Authority Scuttles Credit Card Firm Sale Over Pharmacy Holdings
N12Center · Hebrew2 hours ago
Israel's Competition Authority Blocks Credit Card Firm Sale Over Pharmacy Holdings
Related stories
Credit Card Firm Calá Deal Collapses Amid Antitrust ConcernsSep 14, 2026Discount Bank Faces Deal Collapse for Credit Card Unit Cal1 hour agoDiscount Bank Seeks to Cancel Cal Credit Card Sale Amid Regulatory HurdlesSep 8, 2026Discount Bank Warns Credit Card Firm Sale May CollapseSep 9, 2026Cal Credit Company Appoints New Senior Executives Amid Pending Sale to Union GroupAug 11, 2026Israel Approves Union's Acquisition of Cal Credit Card Company1 hour ago